Form 4: Arteris Insider Sells Shares Under 10b5-1 Plan

Bayview Legacy, LLC, managed by K. Charles Janac, reported the sale of 70,000 shares of Arteris, Inc. common stock for approximately $31.20 per share under a pre-established 10b5-1 trading plan.

Summary

• Bayview Legacy, LLC, through its manager K. Charles Janac, has reported a transaction involving Arteris, Inc. common stock.
• A total of 70,000 shares were disposed of on May 8, 2026.
• The sale was executed under a Rule 10b5-1 trading plan adopted on March 5, 2025.
• The weighted average sale price was $31.1998, with individual transactions ranging from $29.19 to $32.07.
• Following the transaction, Bayview Legacy, LLC beneficially owns 9,049,071 shares of Arteris, Inc. common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it represents a planned sale under a 10b5-1 plan, which is a standard procedure for insiders, rather than an unexpected or opportunistic sale.

Negatives

• Insider selling of a significant number of shares, although conducted under a pre-planned trading strategy, could be perceived negatively by the market.

Risks

• The filing does not explicitly detail risks associated with the transaction itself, beyond the standard implications of insider selling.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding future performance or transactions.

Management Comments

• The transaction was made pursuant to a 10b5-1 trading plan adopted on March 5, 2025.
• K. Charles Janac, as manager of Bayview Legacy, LLC, is deemed to have voting and dispositive power over the shares beneficially owned by the LLC.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for significant shareholders and executives, indicating changes in beneficial ownership. The use of a 10b5-1 plan is a common strategy for insiders to sell shares without facing accusations of insider trading, as it establishes a predetermined schedule or formula for sales.

Stakeholder Impact

• Shareholders may interpret the sale as a signal, though the 10b5-1 plan mitigates concerns about insider knowledge.
• The transaction does not appear to directly impact employees, customers, suppliers, or creditors based on the information provided.

Next Steps

• Continued monitoring of insider transactions for any further changes in beneficial ownership.
• Review of Arteris, Inc.'s overall financial health and strategic announcements for broader investment insights.

Key Dates

Keywords

Arteris Inc, AIP, Form 4, Insider Trading, 10b5-1 Plan, Stock Sale, Beneficial Ownership, Bayview Legacy LLC, K. Charles Janac